9Schade R,Andersohn F,Suissa S,et al.Dopamine agonists and the risk of cardiac-valve regurgitation[J].N Engl J Med,2007,356(1):29-38.
10Zanettini R,Antonini A,Gatto G,et al.Valvular heart disease and the use of dopamine agonists for Parkinson's disease[J].N Engl J Med,2007,356(1):39-46.
3Navin CN, Joseph K, Robe Eol,etal,Examination Protocol for three - Dimensional Echoeardiography Echocardiography, 2004, 21:763 - 766.
4刘延岭,熊鉴然.临床超声心动图学[M].北京:科学出版社,2001.179-183.
5CHEN Q, NOSIR Y F, VIL TTER W B, et al. Accurate Assessment of Mit ral Valve Area in Patients with Mitral Stenosis by three - dimensional Echocardiography [ J ] . J Am Soc Echocardiogrhy, 1997, 10(2): 133 - 140.
6Binder TM, Rosenhek X, Porenta G, et al, Inproved assessment of mitral valve stenosis by volumetric real - time three - dimensional echocardiography J AM Coll Cardiol, 2000, 36(4): 1355 - 1361.
7Levine RA, Handschumacher MD, Sanflippoa J, eta l. Three - dimensional echocardiographic reconstruction of the mitral valve with implication for the diagnosis of mitral valve rolapse. Circulation. 1989. 801 589 - 598.
8Sugeng L, Coon P, Weinert E, et al. Use of real-- time three - dimensional transthoracic echocardiography in the evaluation of mitral valve disease. J Am Soc Echocardiogrhy, 2006, 19:413-421.
9Rajdev S, Nanda NC, Patel V, et al. Live real- time three - dimensional transthoracic echocardiographic assessment of combined valuar and supravaluar aotic stenosis. Am J Geriatr Cardiol, 2006, 15 : 188 - 190.
10Fuknda S, Saracino G, Matsumura Y, eta l. Th tee. dimensional geometry of the tricuspid annulus in health subjects and in patients with functional tricuspid regurgitation : a real -- time, 3 - dimensional echocardiographic study. Circulation, 2006, 114: 1492-1498.
